# Tracking Response to Antidepressants in Advance of Investigational Trials

> **NCT04748276** · — · UNKNOWN · sponsor: **Adams Clinical** · enrollment: 400 (estimated)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** FDA-approved selective-serotonin reuptake inhibitors (SSRIs) and selective-norepinephrine reuptake inhibitors (SNRIs)

## Key facts

- **NCT ID:** NCT04748276
- **Lead sponsor:** Adams Clinical
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-02
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2023-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04748276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04748276, "Tracking Response to Antidepressants in Advance of Investigational Trials". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04748276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*